Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study.
作為MPO-AAV誘導療法的輔助治療,羥氯喹的回顧性觀察性隊列研究。
Clin Kidney J 2024-09-17
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.
ANCA相關血管炎患者的長期結果和存活預後因素。
Nephrol Dial Transplant 2023-11-16
The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
羥氯喹與來氟米特在IgA腎病患者中的療效和安全性:單一中心經驗。
J Nephrol 2024-01-15
Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA nephropathy.
IgA 腎病患者中 Hydroxychloroquine 血藥濃度及其影響。
J Nephrol 2024-07-24
Early reduction in total cholesterol to high-density lipoprotein cholesterol ratio predicts hydroxychloroquine efficacy in treating IgA nephropathy.
早期降低總膽固醇與高密度脂蛋白膽固醇比率可預測治療 IgA 腎病的 hydroxychloroquine 效能。
Ren Fail 2024-08-30